Radiologists, clinical oncologists and industry stakeholders gathered May 16 in London to discuss artificial intelligence (AI) in medical imaging and cancer treatment. The all-day event was organized by the Royal College of Radiologists (RCR) with help from the Alan Turing Institute, Health Data Research UK and the Engineering and Physical Sciences Research Council.

South Korea’s Ministry of Food and Drug Safety announced this week that, for the very first time, it has approved a medical device that uses artificial intelligence (AI) technology.

It’s one of the most frequently discussed questions in radiology today: What kind of long-term impact will artificial intelligence (AI) have on radiologists?

Charles E. Kahn Jr., MD, MS, professor and vice chair of the department of radiology at the University of Pennsylvania’s Perelman School of Medicine in Philadelphia, has been named the editor of RSNA’s new online journal, Radiology: Artificial Intelligence.

Automated and clinical breast density evaluation methods are equally accurate in predicting a patient’s risk of breast cancer, according to a new study published in Annals of Internal Medicine.

Anant Madabhushi, PhD, a professor at Case Western Reserve University in Cleveland, has led significant deep learning research in recent years, but he doesn’t necessarily think this evolving technology will replace radiologists and pathologists any time soon.

The American College of Radiology (ACR) Data Science Institute (DSI) and Society for Imaging Informatics in Medicine (SIIM) are joining forces on May 30 to host the Spring 2018 Data Science Summit: Economics of Artificial Intelligence (AI) in Health Care.

The FDA is working to encourage the use of artificial intelligence (AI) technologies in healthcare, according the prepared remarks by the agency’s commissioner, Scott Gottlieb, MD, at Health Datapalooza in Washington, D.C.